The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study
Saved in:
Di Forti, M., et al., The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study. The Lancet Psychiatry, vol. 6, 2019, p. 427-436.
Ref.
548005
Location:
SIIS SIS
Palabras clave:
Drogodependencias, Cannabis, Efectos, Salud mental, Psicosis, Literatura científica, Datos estadísticos, Europa
Drogodependencias, Cannabis, Efectos, Salud mental, Psicosis, Literatura científica, Datos estadísticos, Europa
Similar Items: The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study
- CHANGING INCIDENCE OF PSYCHOTIC DISORDERS AMONG THE YOUNG IN ZURICH
- DIAGNOSTIC AND SYMPTOMATOLOGICAL FEATURES IN CHRONIC PSYCHOTIC PATIENTS ACCORDING TO CANNABIS USE STATUS
- Continued cannabis use and risk of incidence and persistence of psychotic symptoms: 10 year follow up cohor study
- THE INFLUENCE OF CANNABIS USE EXPETANCIES ON CANNABIS USE AND PSYCHOTIC SYMPTOMS IN PSYCHOSIS
- Impact of non-medical cannabis legalization with market restrictions on health service use and incident cases of psychotic disorder in Ontario, Canada
- TESTS OF CAUSAL LINKAGES BETWEEN CANNABIS USE AND PSYCHOTIC SYMPTOMS